Skip to main content

Closed

KRRO: Korro Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-2154.0%

ROIC-48.2%

Financially safe

Stretched

Debt / equity0.36×

Interest coverage0.0×

Current ratio8.13×

Korro Bio, Inc.

KRRONASDAQ Capital Market·USD·Closed

Korro Bio, Inc.

KRRONASDAQ·USD·Closed

$10.37

−0.77%

$10.37

−$0.08 (0.77%)

52W Range

10thpctl

Volume

0.57×avg

Mkt Cap

103.22MUSD

P/E

-0.9TTM

Div Yield

–ann

52W Range

10thpctl

Volume

0.57×avg

Market Cap

103.22MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings